Neurotrophins Market

Neurotrophins Market : Global Industry Analysis 2015-2019 and Opportunity Assessment 2020-2030

  • Ongoing
  • July 2020
  • REP-GB-11505
Neurotrophins Market

  • US$5,000
  • US$7,500
  • US$10,000

This Neurotrophins market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Neurotrophins market.

This Neurotrophins market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Neurotrophins market.

The neurotrophins are basically neural factors that helps in the growth, survival and programmed cell death of the neurons.  Neurotrophins also regulate axon growth, cell fate decisions, dendrite pruning, and the expression of proteins that are important for basic neurological function. Neurotransmitters and various ion-channels help in the proper functionating of the neuronal factors. Neurotrophins has been widely used for treating various chronic neurological disorders like Alzheimer’s disease, Parkinson's Disease etc. by regulating the cell death pathway. CD11b integrin have been upregulated in peripheral neutrophil. These neutrophils further help in adhesion and migration of neutrophils. These activated neutrophils help in controlling the severity of the disease. Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 are some of the types of neurotrophins that help in the proper functioning of neurons.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Neurotrophins Market: Drivers and Restraints

Increasing prevalence of chronic neurological diseases is the primary factor driving the neurotrophins market.  Also, rising awareness regarding mental health may upsurge the demand for neurotrophins market. Moreover, the neurological disease increases with age, about 5-6% of people above 65 years are more susceptible towards chronic neurological diseases. Hence, rising geriatric population across the globe will drive the neurotrophic market. Additionally, the availability of funding for research and drug development to various pharmaceutical industries in developed economies will also propel the growth of neurotrophins market. On the other hand, lack of high healthcare infrastructure and may deter the growth of neurotrophins market in under developing economies. Neurotrophins works by slowing cell death which can lead to disease onset or clinical decline.

Neurotrophins Market: Overview

 Based on product type, brain growth factor segment will capture the highest revenue share. This is due to increased adoption by various doctors for treating chronic neurological diseases. Among all application of neurotrophins, alzheimer’s disease segment is expected to generate major revenue for global neurotrophins market due to increasing prevalence of the disease. Among all end user, the hospital segment is anticipated to grow at a significant rate over the forecast period due to growing hospital infrastructure in the developed nations.

Neurotrophins Market: Regional Overview

North America will show the high revenue for the neurotrophins market, since the prevalence of chronic neurological disease is more and also the people are more concern about the and brain health. After North America, the Europe region will show the robust growth for the neurotrophins market in the near future, due to availability of better hospital infrastructure and due to regional government initiatives. In Asian countries like China, the rate of the neural disease is high due to the lifestyle pattern, this may show the additional demand for the neurotrophins to treat neurological diseases. The Middle East and Africa are expected to be least lucrative region for neurotrophins market due to lack of awareness about the brain health.

Neurotrophins Market: Key Players

Examples of some of the market participants in Neurotrophins market include Janssen Biotech, Inc.,  Johnson & Johnson, Lonza Groups, FibroGen, Inc., Scil Proteins GmbH, Merck Serono, Scil Proteins GmbH, PeproTech, Inc., GE Healthcare and  others. Prodcut launch is the major strategy followed by the manufacturers to compete in the neurotrophin market. The U.S. Food and Drug Administration on August 2018, approved first drug, Oxervate, for the treatment of neurotrophic keratitis, a rare disease which mainly affects the cornea.

The research report on neurotrophins market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on Neurotrophins market provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on Neurotrophins market:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Report on Neurotrophins market includes regional analysis:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, Italy, France, U.K, Spain, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, ASEAN)
  • Oceania (Australia, New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report on neurotrophins market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Neurotrophins Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Neurotrophins Market: Segmentation

The global neurotrophins market is classified on the basis of product type, application, and end user.

Based on product type, neurotrophins market is segmented into the following:

  • Nerve Growth Factor
  • Brain derived neurotrophic factor
  • Neurotrophin-3
  • Dehydroepiandrosterone sulfate

Based on application, neurotrophins market is segmented into the following:

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Parkinson's Disease
  • Others

Based on end user, neurotrophins market is segmented into the following:

  • Hospitals
  • Diagnostic Centers
  • Others

Report on Neurotrophins market highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Neurotrophins Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Neurotrophins Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Akshay Godge

Akshay Godge

Client Partner - Global Business Development

Our Clients

Request Sample Request customization Request Methodology